Drug delivery compositions comprising lysophosphoglycerolipid
US5725871A · kind A · utility
108Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 15, 1994 |
| Grant date | Mar 10, 1998 |
| Priority date | — |
| Expiry date | Jun 15, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for trans-mucosal delivery, e.g. intranasal, include a lysophosphatidyl-glycerol compound as the adsorption enhancer. The preferred compounds for delivery are insulin and calcitonin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.